Featured
-
Canagliflozin Lowers ESRD Risk in Diabetic Kidney Disease
In a study of patients with type 2 diabetes and chronic kidney disease, canagliflozin, an SGLT2 inhibitor, decreased the risk of end-stage renal disease by 32% compared with placebo. -
Radical Surgery for Metastatic Prostate Cancer Results in Greater Morbidity
Radical prostatectomy for metastatic vs nonmetastatic prostate cancer is associated with a higher risk of complications and longer hospital length of stay. -
Bladder Cancer Risk Elevated in Statin Users
In a large population-based study in Sweden, statin users had significant 31% increased odds of nonmuscle-invasive bladder cancer compared with nonusers. -
Potassium Abnormalities Linked With Death in Heart Failure
Serum potassium concentrations outside the normal range were associated with elevated mortality risk in patients with heart failure. -
Erectile Dysfunction Common in Men With Inflammatory Bowel Disease
In a study, 94% of men with inflammatory bowel disease had erectile dysfunction. -
OCR Probes HIPAA Impediments to Care Coordination
In addition to other input, the federal Office for Civil Rights wants to know how the privacy rule might be amended to encourage information sharing among providers. -
Continuous Learning: Lessons from a Right-Handed Mouse
Inadequate technology can be barriers to physicians fulfilling their continuing medical education obligation. -
The Importance of a Strategic Plan
Physicians must chart the future course of their practice.
Latest Nephrology News
Kidney Disorder Risk Examined Among Various Bipolar Disorder Drug Regimens
Risk for T2DM Increased With Use of 5α-Reductase Inhibitors
Intensive Blood Pressure Control May Cut Mortality in CKD
Latest Urology News
Prostate Cancer ADT Found to Increase Depression Risk
FDA Approves New First-Line Treatment for Advanced RCC
